GlobeNewswire: Lightstone Ventures Contains the last 10 of 12 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T01:35:57ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2018/05/14/1502152/0/en/MediSix-Therapeutics-Launches-with-USD-20M-Series-A-Financing.html?f=22&fvtc=4&fvtv=38251MediSix Therapeutics Launches with USD$20M Series A Financing2018-05-14T23:00:00Z<![CDATA[Company will develop novel CAR-T immune engineering platform targeting T-cell malignancies Company will develop novel CAR-T immune engineering platform targeting T-cell malignancies]]>https://www.globenewswire.com/news-release/2018/01/30/1314008/0/en/FIRE1-Raises-EUR-40-Million-in-Series-C-Financing.html?f=22&fvtc=4&fvtv=38251FIRE1 Raises EUR 40 Million in Series C Financing2018-01-30T07:00:00Z<![CDATA[Connected Health Company Developing Novel Heart Monitoring Solution Connected Health Company Developing Novel Heart Monitoring Solution]]>https://www.globenewswire.com/news-release/2017/09/20/1125145/0/en/Lightstone-Ventures-Closes-New-Life-Sciences-Fund-at-250-Million.html?f=22&fvtc=4&fvtv=38251Lightstone Ventures Closes New Life Sciences Fund at $250 Million2017-09-20T11:27:09Z<![CDATA[Global Venture Firm Strengthens Team to Support Growing Portfolio of Early-stage Medical Device and Biopharmaceutical Companies Global Venture Firm Strengthens Team to Support Growing Portfolio of Early-stage Medical Device and Biopharmaceutical Companies]]>https://www.globenewswire.com/news-release/2017/09/11/1117728/0/en/MediSix-Therapeutics-Signs-Exclusive-Licensing-Agreement-with-the-National-University-of-Singapore.html?f=22&fvtc=4&fvtv=38251MediSix Therapeutics Signs Exclusive Licensing Agreement with the National University of Singapore2017-09-11T23:10:54Z<![CDATA[SINGAPORE, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Lightstone Ventures (LSV) today announced that MediSix Therapeutics Pte Ltd., an early-stage cell therapy company developing novel therapeutics to target T-cell leukemia and lymphoma, has signed an exclusive licensing agreement with the National University of Singapore (NUS).]]>https://www.globenewswire.com/news-release/2017/01/09/1088771/0/en/Foundry-SING1-Launches-Targets-Asian-Clinical-Needs.html?f=22&fvtc=4&fvtv=38251Foundry SING1 Launches, Targets Asian Clinical Needs 2017-01-09T14:35:43Z<![CDATA[<p>Organization Leverages Singapore's Strong, Growing Medtech Ecosystem</p> SINGAPORE--(Marketwired - Jan 9, 2017) -  The Foundry and Lightstone Ventures (LSV) today announced that they have joined forces to launch Foundry SING1, Inc. to identify and address unmet clinical needs in Asia. They have also announced that Karun D. Naga, a medical device executive with multiple previous successes, has been named President and CEO. Foundry Managing Partners Mark Deem and Hanson Gifford and LSV General Partner Michael Carusi have joined the Company's Board of Directors.]]>https://www.globenewswire.com/news-release/2016/09/07/1088770/0/en/Lightstone-Ventures-Adds-Susan-Molineaux-as-Scientific-Advisor.html?f=22&fvtc=4&fvtv=38251Lightstone Ventures Adds Susan Molineaux as Scientific Advisor 2016-09-07T14:24:46Z<![CDATA[MENLO PARK, CA and BOSTON, MA--(Marketwired - Sep 7, 2016) - Lightstone Ventures (LSV) today announced the appointment of Susan M. Molineaux, Ph.D. as Scientific Advisor. In this role, she will assist the LSV biotechnology team with deal sourcing and due diligence. Dr. Molineaux also continues to serve as the President, Chief Executive Officer (CEO) and as a Member of the Board of Directors of Calithera Biosciences (NASDAQ: CALA), and as a Member of the Boards of Directors of Geron Corporation (NASDAQ: GERN) and Theravance Biopharma, Inc. (NASDAQ: TBPH).]]>https://www.globenewswire.com/news-release/2016/04/12/1088767/0/en/FIRE1-Closes-Series-B-Financing-Announces-New-CEO.html?f=22&fvtc=4&fvtv=38251FIRE1 Closes Series B Financing, Announces New CEO 2016-04-12T08:00:00Z<![CDATA[DUBLIN, IRELAND--(Marketwired - Apr 12, 2016) - Foundry Innovation & Research 1, Ltd. ("FIRE1") today announced it has closed its Series B financing, appointed Conor Hanley as President and CEO, and added other new senior leaders to its team including John Britton, Vice President of Commercial Operations, and Fiachra Sweeney, Senior Director of Engineering.]]>https://www.globenewswire.com/news-release/2016/03/02/1088765/0/en/Lightstone-Ventures-Names-Stacy-Enxing-Seng-as-Venture-Partner.html?f=22&fvtc=4&fvtv=38251Lightstone Ventures Names Stacy Enxing Seng as Venture Partner 2016-03-02T13:56:35Z<![CDATA[<p>Medical Device Industry Veteran Brings Proven Track Record, Deep Operational, Leadership Skills</p> MENLO PARK, CA and BOSTON, MA--(Marketwired - Mar 2, 2016) - Lightstone Ventures (LSV) today announced the appointment of Stacy Enxing Seng as Venture Partner. In this role, she will assist the LSV medical device team with deal sourcing, due diligence, and portfolio company growth and management.]]>https://www.globenewswire.com/news-release/2016/02/17/1088763/0/en/Lightstone-Ventures-Closes-50-Million-Singapore-Focused-Fund.html?f=22&fvtc=4&fvtv=38251Lightstone Ventures Closes $50 Million Singapore Focused Fund 2016-02-17T05:01:00Z<![CDATA[<p>Firm Partners With Temasek and EDBI to Capitalize on Growing Life Sciences Ecosystem in Singapore</p> MENLO PARK, CA and BOSTON, MA and SINGAPORE--(Marketwired - Feb 17, 2016) - Lightstone Ventures (LSV) today announced it has closed a US$50 million fund, Lightstone Singapore, L.P., focused on investing in Singapore-based life sciences technologies and companies. ]]>https://www.globenewswire.com/news-release/2014/06/11/1088762/0/en/Lightstone-Ventures-Appoints-Two-New-Venture-Partners.html?f=22&fvtc=4&fvtv=38251Lightstone Ventures Appoints Two New Venture Partners 2014-06-11T14:19:21Z<![CDATA[<p>Mark Deem, Hanson Gifford Further Strengthen Lightstone's Medical Device Team</p> PALO ALTO, CA and BOSTON, MA--(Marketwired - Jun 11, 2014) - Lightstone Ventures (LSV) today announced the addition of Mark Deem and Hanson Gifford as its newest Venture Partners. Deem and Gifford are Managing Partners with The Foundry, the premier medical device incubator and a long-standing partner of the Lightstone team. They join existing LSV Venture Partner Alain Baron, M.D. in the sourcing, evaluation and management of promising medical device companies. ]]>